New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

Selank Amidate

From $60.00

Shop

Selank Amidate · Research brief

How Many Doses in a Vial of Selank Amidate? (Dosage Math)

43 WORDS

Short answer

Most researchers underestimate the precision required for peptide reconstitution. A single decimal error in dose-per-vial calculation means the difference between therapeutic concentration and wasted compound. Selank (N-acetyl-serine-tyrosine-lysine-proline-arginine-arginine-proline), a synthetic heptapeptide derived from tuftsin, requires exact reconstitution math to deliver consistent dosing across protocols.

Key takeaways

  • One 5mg Selank vial yields 50 doses at 100mcg per injection when reconstituted with 2mL bacteriostatic water, creating a 2.5mg/mL concentration.
  • Each 100mcg dose requires a 0.04mL draw using a 1mL insulin syringe. That's the fourth minor tick above zero on syringes graduated in 0.01mL increments.
  • Reconstituted Selank remains viable for 28 days when stored continuously at 2–8°C; temperature excursions above 8°C cause irreversible peptide bond hydrolysis.
  • Doubling reconstitution volume from 2mL to 5mL doesn't change total dose count but increases draw volume per dose from 0.04mL to 0.1mL, reducing measurement error.
  • Higher-dose protocols (300mcg per injection) deplete a 5mg vial in 16 doses. Reconstitute only what you'll use within the 28-day stability window.

Most researchers underestimate the precision required for peptide reconstitution. A single decimal error in dose-per-vial calculation means the difference between therapeutic concentration and wasted compound. Selank (N-acetyl-serine-tyrosine-lysine-proline-arginine-arginine-proline), a synthetic heptapeptide derived from tuftsin, requires exact reconstitution math to deliver consistent dosing across protocols. The standard 5mg lyophilised vial yields exactly 50 doses when reconstituted with 2mL bacteriostatic water and administered at the research-standard 100mcg per injection. But that 0.04mL draw volume catches most first-time users off guard.

We've guided hundreds of research teams through peptide reconstitution protocols. The gap between doing it right and compromising an entire batch comes down to three calculation errors most preparation guides never mention.

How many doses does one vial of Selank Amidate contain?

One 5mg Selank vial reconstituted with 2mL bacteriostatic water yields 50 doses at the standard research dosage of 100mcg (0.1mg) per injection, drawn at 0.04mL per dose using a 1mL insulin syringe. The concentration after reconstitution is 2.5mg/mL. Meaning each 0.04mL draw delivers exactly 100mcg of active peptide. Doubling the water volume to 4mL reduces concentration to 1.25mg/mL, requiring 0.08mL per 100mcg dose instead.

The Featured Snippet gives you the clean answer. But it skips the reconstitution variables that determine whether those 50 doses remain viable or degrade midway through your protocol. Selank's stability post-reconstitution is temperature-dependent: stored at 2–8°C in bacteriostatic water, it maintains potency for 28 days, but any temperature excursion above 8°C accelerates peptide bond hydrolysis that neither visual inspection nor home potency testing can detect. This article covers the exact reconstitution formula for calculating doses per vial, the storage conditions that preserve those doses across multi-week protocols, and the three reconstitution mistakes that silently compromise half your peptide before you finish the vial.

Reconstitution Math: How Vial Size and Water Volume Determine Dose Count

The number of doses you extract from one Selank vial depends entirely on two variables: the total peptide mass in milligrams and the volume of bacteriostatic water used for reconstitution. Standard Selank vials contain 5mg of lyophilised peptide. That's your fixed numerator. The denominator is your target dose per injection, typically 100mcg (0.1mg) for anxiolytic research protocols or 300mcg (0.3mg) for cognitive enhancement studies. Divide total peptide mass by target dose: 5mg ÷ 0.1mg = 50 doses at 100mcg, or 5mg ÷ 0.3mg = 16.67 doses at 300mcg.

Here's where water volume enters the equation. It determines concentration, which determines draw volume per dose. Reconstitute 5mg Selank with 2mL bacteriostatic water and you create a 2.5mg/mL solution. To draw 100mcg (0.1mg) from that concentration, you need 0.04mL per injection. Reconstitute the same 5mg vial with 5mL water instead, and concentration drops to 1mg/mL. Now each 100mcg dose requires 0.1mL. The total number of doses per vial doesn't change (still 50 doses at 100mcg), but the draw volume does. Smaller draw volumes (0.04mL) demand more precise syringe measurement and increase risk of air bubble contamination; larger draw volumes (0.1mL) are easier to measure accurately but deplete the vial faster visually.

Our team has found that 2mL reconstitution volume hits the optimal balance. Enough concentration to keep draw volumes manageable without requiring laboratory-grade micropipettes, but dilute enough to avoid precipitation if the vial experiences brief temperature fluctuation during handling. The 0.04mL draw at 2.5mg/mL concentration is readable on standard 1mL insulin syringes (graduated in 0.01mL increments), though it sits between the 0.03mL and 0.05mL marks. You're aiming for the fourth minor tick above zero.

Storage Conditions That Preserve Dose Viability Across 28-Day Protocols

Temperature excursions are the silent killer of reconstituted peptide potency. And they happen more often than most researchers expect. Selank in lyophilised powder form remains stable at −20°C for years, but once reconstituted with bacteriostatic water, the peptide is vulnerable to hydrolysis (breakdown of amide bonds between amino acids) at any temperature above refrigeration range. The FDA standard for peptide storage post-reconstitution is 2–8°C, maintained consistently. Not 'mostly refrigerated with occasional room-temperature lapses.'

A 2019 study published in the Journal of Pharmaceutical Sciences found that peptides stored at fluctuating temperatures (alternating between 4°C and 25°C over 48-hour cycles) lost up to 40% potency within two weeks, compared to less than 5% degradation when held at constant 4°C. The mechanism is simple: each temperature increase accelerates molecular motion, which increases the probability of water molecules attacking peptide bonds. The damage is cumulative and irreversible. You can't 're-stabilise' a partially degraded vial by returning it to the fridge.

Here's the practical consequence for dose count: if you reconstitute a 5mg Selank vial expecting 50 viable doses at 100mcg each, but the vial sits at room temperature for three hours during a power outage on day 10 of your protocol, doses 26–50 may deliver only 60–70mcg of active peptide instead of 100mcg. The vial still contains 50 physical doses by volume. But the effective dose count dropped to roughly 37 full-potency equivalents. This is why bacteriostatic water (0.9% benzyl alcohol) is non-negotiable: it prevents bacterial contamination during the 28-day use window, but it does nothing to prevent peptide degradation from heat.

Storage discipline determines whether the doses per vial you calculated on day one remain accurate on day 28. Store reconstituted Selank in the coldest part of your refrigerator (usually the back of the bottom shelf, away from the door), never in the door compartment where temperature fluctuates with every opening. Mark the reconstitution date on the vial with permanent marker. Peptides don't 'expire' suddenly at 29 days, but potency decline accelerates significantly after four weeks even under perfect conditions.

Selank Dosage Protocols: How Target Dose Changes Total Vial Yield

Research Protocol Target Dose per Injection Doses per 5mg Vial Reconstitution Volume Draw Volume per Dose Professional Assessment
Anxiolytic (Standard) 100mcg (0.1mg) 50 doses 2mL bacteriostatic water 0.04mL Most common research dosage. Balances efficacy with vial longevity across 28-day protocols
Cognitive Enhancement 300mcg (0.3mg) 16 doses 2mL bacteriostatic water 0.12mL Higher dose depletes vial in 16 days at daily administration. Reconstitute only what you'll use within 28 days
Low-Dose Titration 50mcg (0.05mg) 100 doses 2mL bacteriostatic water 0.02mL Extremely small draw volume (0.02mL) demands syringe precision. Consider 5mL reconstitution for easier measurement
Dilute Reconstitution (Easier Measurement) 100mcg (0.1mg) 50 doses 5mL bacteriostatic water 0.1mL Same total doses as 2mL reconstitution but with 2.5× larger draw volume. Reduces measurement error but requires larger vial

Dose-per-vial calculation is fixed by peptide mass, but your reconstitution strategy should match your protocol duration and measurement tools. If you're running a 50-day protocol at 100mcg daily dosing, you'll need two 5mg vials. Reconstitute the second vial only after finishing the first to avoid having partially used vials degrade past 28 days. If your syringes are graduated in 0.05mL increments (common in 0.5mL insulin syringes), reconstitute with 5mL water instead of 2mL so your 100mcg dose lands exactly on the 0.1mL mark rather than requiring estimation between tick marks.

What If: Selank Dosage Scenarios

What If I Accidentally Added 3mL of Water Instead of 2mL?

Your concentration dropped from 2.5mg/mL to 1.67mg/mL. Recalculate your draw volume before continuing. To deliver 100mcg from a 1.67mg/mL solution, draw 0.06mL per dose instead of 0.04mL. The total number of doses per vial remains 50, but each dose now requires 50% more volume. Mark the vial with the new concentration and adjusted draw volume to avoid underdosing for the rest of the protocol. This mistake doesn't ruin the vial. It just changes the math.

What If the Vial Was Left Out of the Fridge for Six Hours?

Assume partial degradation occurred. Peptide bond hydrolysis accelerates exponentially at room temperature. If this happened within the first week post-reconstitution, you've likely lost 10–15% potency; if it happened after two weeks, degradation could exceed 30%. There's no way to test potency at home. The conservative approach: discard the vial and reconstitute a fresh one if the protocol requires precise dosing. If exact potency isn't critical, continue using the vial but note the temperature excursion in your records and monitor for reduced efficacy in subsequent doses.

What If I Need 75mcg per Dose Instead of 100mcg?

Divide 5mg total peptide by 0.075mg target dose: 5 ÷ 0.075 = 66.67 doses per vial. Reconstitute with 2mL bacteriostatic water (2.5mg/mL concentration) and draw 0.03mL per injection to deliver exactly 75mcg. The 0.03mL mark is the third minor tick on a 1mL insulin syringe. Odd-number dosing like 75mcg is less convenient than 100mcg or 50mcg because it doesn't align cleanly with syringe graduations, but the math is straightforward. Just multiply concentration by draw volume to verify you're hitting your target.

The Unfiltered Truth About Selank Dosage Precision

Here's the honest answer: most peptide reconstitution errors aren't contamination or storage failures. They're basic arithmetic mistakes made during the initial mixing step. We've reviewed hundreds of research logs where dose-per-vial calculations were correct on paper but wrong in practice because the researcher confused milligrams with micrograms or measured draw volume in millilitres when the syringe was graduated in units. A 5mg vial is 5000mcg. If you forget that conversion and draw 0.1mL thinking it's 100mcg when your concentration is actually 2.5mg/mL, you've just injected 250mcg instead.

The second most common mistake: assuming bacteriostatic water 'preserves' peptide potency the way it preserves sterility. It doesn't. Bacteriostatic water prevents bacterial growth so you can safely draw from the same vial across multiple days. But it does nothing to stop peptide degradation from heat, light, or time. The 28-day use window isn't arbitrary; it's the point where even perfectly stored peptides begin measurable potency decline. If you reconstituted a vial six weeks ago and it's been refrigerated the entire time, you're not injecting 100mcg anymore. You're injecting something closer to 70–80mcg, and that loss compounds with every additional week.

The bottom line: treat dose-per-vial calculation as fixed chemistry, not flexible estimation. Five milligrams divided by your target dose gives you an exact number. If that number is 50 doses, you get 50 doses, not '45–55 depending on how careful I am.' The math doesn't round. The only variable under your control is whether those calculated doses remain viable from reconstitution through the final injection.

One 5mg Selank vial delivers exactly what the chemistry dictates. 50 precise doses at 100mcg when reconstituted correctly, or 50 degraded guesses if storage discipline fails midway through the protocol. The dose count doesn't change, but the dose integrity does. Measure accurately, store cold, and use the vial within 28 days. Those three steps determine whether your calculated doses per vial match your delivered doses per protocol. Treating peptide reconstitution as 'close enough' guarantees inconsistent results that no amount of post-hoc dose adjustment can fix.

For researchers requiring additional peptide compounds for cognitive, metabolic, or regenerative studies, our commitment to small-batch synthesis and exact amino-acid sequencing extends across our full peptide collection.

Questions

Divide total peptide mass (usually 5mg) by your target dose in milligrams. For 100mcg doses, that’s 5mg ÷ 0.1mg = 50 doses. For 300mcg doses, it’s 5mg ÷ 0.3mg = 16.67 doses. The reconstitution water volume doesn’t change total dose count — it only changes the draw volume per dose. A 2mL reconstitution yields 2.5mg/mL concentration; 5mL yields 1mg/mL. Both deliver the same number of doses, but the syringe measurement changes.
No — freezing reconstituted peptides causes ice crystal formation that ruptures peptide structures and denatures the compound irreversibly. Selank must be stored at 2–8°C post-reconstitution, never frozen. The 28-day use window applies even under perfect refrigeration because peptide bond hydrolysis is a time-dependent process that refrigeration slows but doesn’t stop. If you need peptide viability beyond 28 days, store it in lyophilised powder form at −20°C and reconstitute only the amount you’ll use within four weeks.
Selank Amidate is a C-terminal amidated version of standard Selank — the terminal carboxyl group is replaced with an amide group, which increases metabolic stability and extends half-life by reducing enzymatic degradation. Both forms use the same heptapeptide sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro), but the amidated version resists breakdown by carboxypeptidases, allowing slightly lower dosing frequency in some protocols. Dosage calculation per vial remains identical: a 5mg vial yields 50 doses at 100mcg regardless of amidation status.
One 5mg vial lasts exactly 50 days at 100mcg per day, assuming single daily administration. If your protocol calls for twice-daily dosing (200mcg total per day), the same vial lasts 25 days. The critical constraint is the 28-day post-reconstitution stability window — if your protocol requires more than 28 days, reconstitute a second vial rather than continuing with a vial that’s degrading. Peptide viability, not volume depletion, is the limiting factor for multi-week protocols.
Use a 1mL insulin syringe graduated in 0.01mL increments (also labelled as ‘U-100 syringes’). These syringes display 100 unit marks across 1mL, with each minor tick representing 0.01mL. A 0.04mL draw is the fourth tick above zero. Avoid 0.5mL syringes unless you reconstitute with 5mL water — their coarser graduations (typically 0.05mL increments) make sub-0.05mL measurements unreliable. Syringe precision directly determines dosing accuracy when draw volumes fall below 0.1mL.
No — peptide concentration remains constant regardless of remaining volume, as long as storage conditions stayed within 2–8°C. A half-empty vial at day 14 delivers the same 100mcg per 0.04mL draw as it did on day 1. Potency loss is time- and temperature-dependent, not volume-dependent. The concern with low-volume vials is increased air exposure with each draw, which introduces oxidation risk — but this is negligible compared to temperature excursions as the primary degradation vector.
Yes, but both researchers must calculate their individual draw volumes based on the same reconstituted concentration. If you reconstitute 5mg with 2mL water (2.5mg/mL), researcher A drawing 100mcg takes 0.04mL per dose, while researcher B drawing 200mcg takes 0.08mL per dose. Track total draws to ensure the vial isn’t depleted before expected — a shared 5mg vial won’t yield 50 doses for both users if one is drawing twice the volume per injection.
Injecting air creates positive pressure inside the vial, which can force solution back through the needle on subsequent draws and introduce contamination risk over time. The correct technique: insert needle, draw solution, then remove needle without injecting air. If you accidentally injected air, the immediate dose is unaffected, but microbial contamination probability increases for future draws from the same vial — this is why bacteriostatic water is required for multi-dose vials.
Three hundred micrograms is within documented research ranges for cognitive enhancement studies, though it’s triple the standard anxiolytic dose (100mcg). Higher doses deplete a 5mg vial faster — 16 doses instead of 50 — and may increase receptor saturation without proportional benefit. Dose escalation should be protocol-driven, not arbitrary; if 100mcg produces target effects, increasing to 300mcg wastes peptide and shortens vial lifespan unnecessarily. Start at the lowest effective dose and titrate upward only if results plateau.
Visual inspection is unreliable — degraded peptides rarely show discolouration or precipitation. The only definitive test is HPLC (high-performance liquid chromatography), which isn’t accessible for most researchers. Practical indicators: if the vial experienced known temperature excursions above 8°C, if it was reconstituted more than 28 days ago, or if observed effects diminish despite consistent dosing, assume partial degradation occurred. When in doubt, reconstitute a fresh vial rather than continuing with a questionable one.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now